Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease ManifestationsNadera Sweiss, Timothy B. Niewold, Robert P. Baughman et al.|PLoS ONE|2010Cited by 140
Ocrelizumab: a step forward in the evolution of B-cell therapyFariha Kausar, Nadera Sweiss, Khader N. Mustafa et al.|Expert Opinion on Biological Therapy|2009Cited by 64
IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus ErythematosusNadera Sweiss, Jerrold S. Levine, Ronghai Bo et al.|PLoS ONE|2010Cited by 57
Correction: Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease ManifestationsNadera Sweiss, Timothy B. Niewold, Rafah Salloum et al.|PLoS ONE|2010Cited by 21